Background illustration for clinical trials search

Paid Clinical Trials Oregon

Discover 1,086 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Bilateral Infant Stimulation Study

for
Parent-Child Relations, Preterm Birth, Stress Reaction,
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 0+

Code: NCT06353243

Recruiting

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

for
Amblyopia
Location: Boston MA, Milford CT, New York NY, Philadelphia PA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 3 - 13

Code: NCT04378790

Phase 3, Recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for
Acute Myeloid Leukemia,
Location: Halifax, Brunswick ME, Portland ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05564390

Phase 2, Recruiting

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

for
B-cell Acute Lymphoblastic Leukemia,
Location: Boston MA, New Haven CT, Valhalla NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 25

Code: NCT06395103

Phase 1, Phase 2, Recruiting

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Saint John, Damariscotta ME, Brunswick ME, Augusta ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04269902

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

for
Childhood Medulloblastoma
Location: Halifax, Boston MA, Providence RI, Hartford CT,
Sponsor: Children's Oncology Group

Sex: All

Age: 4 - 21

Code: NCT05382338

Phase 3, Recruiting

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

for
Lymphatic Malformations
Location: Boston MA, Philadelphia PA, Washington D.C. DC,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0 - 70+

Code: NCT05948943

Phase 2, Phase 3, Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Brewer ME, Rockport ME, Belfast ME, Damariscotta ME,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06616584

Phase 2, Phase 3, Recruiting

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

for
Migraine
Location: Nashua NH, Stamford CT, Morristown NJ, Philadelphia PA,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05125302

Phase 3, Recruiting

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

for
Acral Lentiginous Melanoma,
Location: Jacksonville NC, Goldsboro NC, Clinton NC,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04511013

Phase 2, Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Saint John, Bath ME, Portland ME, Scarborough ME,
Sponsor: NRG Oncology

Sex: Male

Age: 18+

Code: NCT05946213

Phase 3, Recruiting

A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum

for
Pyoderma Gangrenosum
Location: Boston MA, Lebanon NH, Quebec, Lake Success NY,
Sponsor: LEO Pharma

Sex: All

Age: 18+

Code: NCT06624670

Phase 3, Recruiting

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

for
Metastatic Nasopharyngeal Carcinoma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06029270

Phase 2, Recruiting

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

for
Pediatric Migraine
Location: East Greenwich RI, Cromwell CT, Commack NY, Stamford CT,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04649242

Phase 3, Recruiting

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

for
Mitral Valve Regurgitation
Location: Boston MA, Hartford CT, New Haven CT, Roslyn NY,
Sponsor: Medtronic Cardiovascular

Sex: All

Age: 18+

Code: NCT03242642

Recruiting

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

for
Advanced Lung Non-Small Cell Carcinoma,
Location: Boston MA, Wynnewood PA, Bryn Mawr PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03191149

Phase 2, Recruiting

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Scarborough ME, Providence RI, Commack NY, Norwalk CT,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06580314

Phase 3, Recruiting

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

for
Pain
Location: Boston MA, Quebec, The Bronx NY, Trevose PA,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT01719055

Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for
Advanced Solid Tumor, Advanced Malignant Neoplasm,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 12+

Code: NCT04585750

Phase 1, Phase 2, Recruiting

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

for
Intracranial Meningioma, Recurrent Meningioma,
Location: Boston MA, Hartford CT, New Haven CT,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT02523014

Phase 2, Recruiting

Popular cities in Oregon